About this Event
Join us on February 19, 2025, at the prestigious Fairmont Hotel Vancouver for an engaging and insightful symposium focused on the latest advancements in cell signaling research.
This event will bring together leading experts from academia and industry to explore cutting-edge discoveries in kinases and their pathways, as well as their therapeutic implications for treating complex diseases. Featuring keynote speeches, panel discussions, and networking opportunities, the symposium is an exceptional platform for researchers, clinicians, and biotech professionals to connect, collaborate, and drive innovation in this vital field.
Welcome to this opportunity to stay at the forefront of cell signaling breakthroughs and contribute to shaping the future of therapeutic development.
Speakers
Dr. Xin-Yuan Fu
Discover of the JAK-STAT Pathway
Senior Chair Professor at West China Hospital
Founding Director of Tsinghua Institute of Genome Research
Dr. Steven Pelech
UBC Professor
Founder of Kinexus Bioinformatics
Renowned Expert in Cell Signaling and COVID-19 Research
Dr. Zu-hua Gao
Renowned Pathologist
Fellow of the Royal Society of Medicine (London UK)
Fellow of the Canadian Academy of Health Sciences
Head of Pathology at UBC
Dr. Linda Malkas
M.T. & B.A. Ahmadinia Professor in Molecular Oncology
Dean, Translational Science, External Affairs
Professor, Molecular Diagnostics and Experimental Therapeutics
Expert in DNA Replication, Cancer Therapeutics, and Developer of PCNA-Targeting Drug
Dr. Jared Johnson
Scientist at the Dana-Farber Cancer Institute
Dr. Zaihui Zhang
Co-founder of Signalchem Lifesciences Corporation
Dr. Rafik Terra
Expert in Biomedical Sciences and Hematology Laboratory Quality
Scientific Director of Clinical Immunology at Hôpital Maisonneuve-Rosemont
Dr. Earl May
Senior Director at AssayQuant Technologies
Dr. Hicham Zegzouti
Senior Research Scientist at the R&D Department of Promega
Event Venue & Nearby Stays
Fairmont Hotel Vancouver, 900 West Georgia Street, Vancouver, Canada
CAD 126.00 to CAD 262.50